Business / Finance

RSS

Thermo Fisher acquires Phadia

Thermo Fisher Scientific Inc., the world leader in serving science, today reported that it has completed its previously announced acquisition of Phadia, a global leader in blood tests for the clinical diagnosis and monitoring of allergies and autoimmune diseases.

From Thermo Fisher Scientific Inc. 24 Aug 2011

MedPro Safety Products second quarter net loss decreases to $2.9 million

MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection, today reported on several key financial highlights for the second quarter ended June 30, 2011, as well as significant corporate developments.

23 Aug 2011

BioLineRx second quarter net loss decreases to NIS 16.4 million

BioLineRx Ltd., a biopharmaceutical development company, today reported its results for the second quarter ending June 30, 2011.

23 Aug 2011

Medtronic first quarter global revenue increases 7% to $4.049 billion

Medtronic, Inc. today announced financial results for its first quarter of fiscal year 2012, which ended July 29, 2011.

From Medtronic 23 Aug 2011

Nepstar board authorizes share repurchase program

China Nepstar Chain Drugstore Ltd., the largest drugstore chain in China based on the number of directly operated stores, today announced that its board of directors has authorized a share repurchase program.

23 Aug 2011

KalVista raises £8 million in series A round of funding

KalVista Pharmaceuticals, a new ophthalmology company with a focus on diabetic macular edema (DME), has raised £8 million in a series A round from leading life sciences investors Novo A/S and SV Life Sciences.

23 Aug 2011

Spinifex secures AU$6.25 million in expanded Series B funding

Spinifex Pharmaceuticals, an Australian pain drug development company, today announced it has secured a further AU$6.25 million of venture capital investment from GBS Venture Partners Limited, Brandon Capital Partners Pty Limited, Uniseed Management Pty Limited and UniQuest Pty Limited to fund the development of its pain management drug, EMA401.

23 Aug 2011

NextDocs receives $10.3 million in Series A financing

NextDocs Corporation, the global leader in Microsoft SharePoint based software solutions for life sciences industries, today announced that the Company has received $10.3 million in a Series A financing from OpenView Venture Partners.

23 Aug 2011

Crimson announces publication of Japan Medical Device Digest

Crimson Life Sciences, a division of TransPerfect and the world's only ISO 13485 and ISO 14971-certified translation provider, today announced the publication of their Japan Medical Device Digest, a free monthly report that provides English translations of Japanese-language news items.

23 Aug 2011

CVS Caremark announces results of Consent Solicitation from registered holders

CVS Caremark Corporation announced today the results of its previously announced solicitation of consents from the registered holders as of 5:00 p.m., New York City time on August 8, 2011 of its 6.125% Senior Notes due August 15, 2016 to terminate the replacement capital covenant, which was entered into on May 25, 2007, for the benefit of the holders of the Notes in connection with the issuance of its 6.302% Enhanced Capital Advantaged Preferred Securities due 2062.

23 Aug 2011

Aptiv Solutions acquires Medical Device Consultants

Aptiv Solutions announced today the acquisition of Medical Device Consultants, Inc. (MDCI), a provider of expert medical device consulting and clinical trial management and execution.

23 Aug 2011

Nepstar second quarter revenue increases 7.3% to US$93.8 million

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2011.

23 Aug 2011

China Medicine Audit Committee dismisses auditor Frazer Frost

China Medicine Corporation, a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese medicines, and other health products in the People's Republic of China, today announced that the Audit Committee of the Board of Directors of the Company, has dismissed Frazer Frost as the Company's independent auditor, effective August 16, 2011.

23 Aug 2011

Ventas receives court ruling to collect $102 million from judgment against HCP

Ventas, Inc. said today that the United States District Court for the Western District of Kentucky has ruled that Ventas may immediately collect the $102 million compensatory damages judgment against HCP, Inc. that it was awarded by a federal jury in 2009.

23 Aug 2011

MedClean second quarter total revenue increases 44.6% to $190,557

MedClean Technologies, Inc. today announced financial results for the second quarter ended June 30, 2011.

23 Aug 2011

IFMC changes company name to Telligen

IFMC has changed its name to Telligen, effective today.

23 Aug 2011

Medical Facilities announces cash dividend payment of Cdn$0.0917 per common share

Medical Facilities Corporation announced today that a cash dividend payment of Cdn$0.0917 per Common Share will be payable on September 15, 2011 to holders of record of Common Shares at the close of business on August 31, 2011.

23 Aug 2011

New report: Molecular imaging market to reach $6 billion by 2015

By 2015, it is anticipated that the molecular imaging (MI) market will achieve a value of over $6 billion, according to a new report on companiesandmarkets.com.

23 Aug 2011

HRS, KGH reduce bed rental expenditures by 83%

Leveraging their membership with Amerinet affiliate Health Resource Services (HRS), Kennewick General Hospital (KGH), a 101-bed acute care facility in southeastern Washington state, decreased its bed rental expenditures by 83 percent, and positively impacted quality patient care through the economical acquisition of Hill-Rom critical care and bariatric beds.

23 Aug 2011

Fibrocell Science announces completion of $22.8M private placement

Fibrocell Science, Inc. announced today that the Company has completed a private placement with certain accredited investors, pursuant to which the Company sold to the purchasers an aggregate of 41,409,458 shares of Company common stock at a purchase price of $0.55 per share.

23 Aug 2011